170 related articles for article (PubMed ID: 27742595)
1. Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide.
Żółtowska K; Piotrowska U; Oledzka E; Luchowska U; Sobczak M; Bocho-Janiszewska A
Eur J Pharm Sci; 2017 Jan; 96():440-448. PubMed ID: 27742595
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Poly(ester-urethane) Carriers Exhibiting Controlled Release of Epirubicin.
Żółtowska K; Piotrowska U; Oledzka E; Kuras M; Zgadzaj A; Sobczak M
Pharm Res; 2017 Apr; 34(4):780-792. PubMed ID: 28120174
[TBL] [Abstract][Full Text] [Related]
3. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
4. Controlled release kinetics of p-aminosalicylic acid from biodegradable crosslinked polyesters for enhanced anti-mycobacterial activity.
Dasgupta Q; Madras G; Chatterjee K
Acta Biomater; 2016 Jan; 30():168-176. PubMed ID: 26596566
[TBL] [Abstract][Full Text] [Related]
5. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
[TBL] [Abstract][Full Text] [Related]
6. Polyester-based microdisc systems for sustained release of neuroprotective phosphine-borane complexes.
Janus DA; Lieven CJ; Crowe ME; Levin LA
Pharm Dev Technol; 2018 Nov; 23(9):882-889. PubMed ID: 28524719
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and evaluation of antibacterial properties of epirubicin loaded PHB and PHBV nanoparticles.
Perveen K; Masood F; Hameed A
Int J Biol Macromol; 2020 Feb; 144():259-266. PubMed ID: 31821825
[TBL] [Abstract][Full Text] [Related]
8. Synthetic biodegradable polyesters for implantable controlled-release devices.
Pothupitiya JU; Zheng C; Saltzman WM
Expert Opin Drug Deliv; 2022 Oct; 19(10):1351-1364. PubMed ID: 36197839
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
10. Novel biodegradable blend matrices for controlled drug release.
Lin M; Meng S; Zhong W; Li Z; Du Q; Tomasik P
J Pharm Sci; 2008 Oct; 97(10):4240-8. PubMed ID: 18271038
[TBL] [Abstract][Full Text] [Related]
11. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
[TBL] [Abstract][Full Text] [Related]
12. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.
Pitt CG; Gratzl MM; Jeffcoat AR; Zweidinger R; Schindler A
J Pharm Sci; 1979 Dec; 68(12):1534-8. PubMed ID: 529046
[TBL] [Abstract][Full Text] [Related]
13. Branched biodegradable polyesters for parenteral drug delivery systems.
Breitenbach A; Li YX; Kissel T
J Control Release; 2000 Feb; 64(1-3):167-78. PubMed ID: 10640655
[TBL] [Abstract][Full Text] [Related]
14. New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.
Chudecka-Głaz A; Szczeblińska J; Cymbaluk-Płoska A; Kohn J; El Fray M
J Microencapsul; 2016 Dec; 33(8):702-711. PubMed ID: 27705049
[TBL] [Abstract][Full Text] [Related]
15. Gradiently degraded electrospun polyester scaffolds with cytostatic for urothelial carcinoma therapy.
Wang J; Wang G; Shan H; Wang X; Wang C; Zhuang X; Ding J; Chen X
Biomater Sci; 2019 Feb; 7(3):963-974. PubMed ID: 30569055
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives of use of polymer carriers of epidoxorubicin and cyclophosphamide in cancer therapy].
Zółtowska K; Sobczak M
Polim Med; 2014; 44(1):51-62. PubMed ID: 24918656
[TBL] [Abstract][Full Text] [Related]
17. New segmented copolymers containing poly(epsilon-caprolactone) and etheramide segments for the controlled release of bioactive compounds.
Quaglia F; Vignola M; De Rosa G; La Rotonda M; Maglio G; Palumbo R
J Control Release; 2002 Oct; 83(2):263-71. PubMed ID: 12363452
[TBL] [Abstract][Full Text] [Related]
18. Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine--the effect of copolymer chain microstructure on drug release rate.
Jelonek K; Kasperczyk J; Li S; Dobrzynski P; Jarzabek B
Int J Pharm; 2011 Jul; 414(1-2):203-9. PubMed ID: 21621596
[TBL] [Abstract][Full Text] [Related]
19. A flexible polymersome system with tunable morphology and release profiles for efficient intracellular delivery.
Croitoru-Sadger T; Leichtmann-Bardoogo Y; Mizrahi B
Int J Pharm; 2016 Jul; 508(1-2):34-41. PubMed ID: 27139143
[TBL] [Abstract][Full Text] [Related]
20. Microspheres from new biodegradable poly(ester amide)s with different ratios of L- and D-alanine for controlled drug delivery.
Vera M; Puiggalí J; Coudane J
J Microencapsul; 2006 Sep; 23(6):686-97. PubMed ID: 17118884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
